Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.7K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Translation01:31

Translation

154.5K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
154.5K
Translation01:31

Translation

17.2K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
17.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.3K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

107
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
107
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

134
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ZnO nanoparticle induced electrical modulation and charge storage in <i>Aloe vera</i> leaves.

Nanoscale advances·2026
Same author

Aloe vera-derived NiCo<sub>2</sub>O<sub>4</sub> electrodes with improved cyclic efficiency for supercapattery applications.

Scientific reports·2025
Same author

Reply to: "Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens".

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Exploration of pH-Driven Morphology and Defect Evolution in Nickel Cobalt Carbonate Hydroxide Nanomaterial for Supercapacitor Applications.

ChemSusChem·2025
Same author

Green synthesis of <i>Aloe vera</i>-assisted Co<sub>3</sub>O<sub>4</sub> nanostructures: structural, electronic, optical, and electrochemical insights for supercapattery applications.

RSC advances·2025
Same author

Charge transport dynamics and energy storage implications of nickel cobalt carbonate hydroxide interaction with the <i>Aloe vera</i> leaf matrix.

Nanoscale advances·2025

Related Experiment Video

Updated: Dec 15, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.8K

Wilson disease.

Annu Aggarwal1,2, Mohit Bhatt1,3

  • 1Wilson Disease Clinic, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute (KDAH).

Current Opinion in Neurology
|July 14, 2020
PubMed
Summary

This review details expanded knowledge of Wilson disease's clinical features and treatments. It also covers similar disorders, aiding in understanding copper metabolism and improving patient care.

More Related Videos

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.6K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.3K

Related Experiment Videos

Last Updated: Dec 15, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.8K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.6K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.3K

Area of Science:

  • Hepatology and Gastroenterology
  • Neurology
  • Genetics and Rare Diseases

Background:

  • Wilson disease is a rare genetic disorder of copper metabolism.
  • Its clinical presentation is diverse, affecting multiple organ systems.
  • Understanding Wilson disease mimics is crucial for accurate diagnosis.

Purpose of the Study:

  • To review recent advancements in Wilson disease phenotype and treatment.
  • To survey disorders with similar pathophysiology or clinical symptoms.
  • To enhance understanding of human copper homeostasis.

Main Methods:

  • Literature review of recent studies on Wilson disease.
  • Analysis of clinical presentations across different age groups.
  • Survey of genetic disorders mimicking Wilson disease.

Main Results:

  • Expanded understanding of Wilson disease's clinical spectrum, including atypical presentations.
  • Identification of Wilson disease mimics, aiding in copper metabolism research.
  • Better-defined outcomes for existing treatments and novel therapeutic strategies under investigation.

Conclusions:

  • Recent research has broadened the understanding of Wilson disease and related disorders.
  • These findings will impact clinical management and guide future research.
  • Novel therapeutic approaches show promise for Wilson disease treatment.